Literature DB >> 20214608

Bacteriophage for biocontrol of foodborne pathogens: calculations and considerations.

Steven Hagens1, Martin J Loessner.   

Abstract

The use of phage or phage products in food production has recently become an option for the food industry as a novel method for biocontrol of unwanted pathogens, enhancing the safety of especially fresh and ready-to-eat food products. While it can be expected that many more phage products currently under development might become available in the future, several questions may be raised concerning the use of such products, regarding both immediate and long-term efficacy, consumer safety, and application methods. The available evidence suggests that, with a few caveats, safety concerns have been satisfactorily addressed. Answers concerning efficacy are more complex, depending on particular applications or the target pathogens. To ensure long-term efficacy beyond what can be tested on a laboratory scale, food safety concepts employing phages will have to be well-thought out and may involve rotation schemes as used with bacterial starter cultures, the use of phage cocktails, or application of phages combined with other antimicrobials. This review will discuss these issues on the basis of the available literature as well as providing an outlook on the potential of phages in future applications.

Entities:  

Mesh:

Year:  2010        PMID: 20214608     DOI: 10.2174/138920110790725429

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  81 in total

1.  Phage-based biocontrol strategies to reduce foodborne pathogens in foods.

Authors:  Lawrence D Goodridge; Bledar Bisha
Journal:  Bacteriophage       Date:  2011-05-01

Review 2.  Listeria phages: Genomes, evolution, and application.

Authors:  Jochen Klumpp; Martin J Loessner
Journal:  Bacteriophage       Date:  2013-10-24

3.  Genome analysis of Salmonella phage vB_SalM_8-19 (genus Rosemountvirus).

Authors:  Cong Cong; Wei Bing Dong; Cui Hui Jing; Yuan Yu Yu; Xu Yong Ping; Wang Li Li; Li Shu Ying; Li Ji Bin; Xu Mu; Li Xiao Yu
Journal:  Arch Microbiol       Date:  2021-01-02       Impact factor: 2.552

Review 4.  Bioengineered probiotics, a strategic approach to control enteric infections.

Authors:  Mary Anne Roshni Amalaradjou; Arun K Bhunia
Journal:  Bioengineered       Date:  2013-01-17       Impact factor: 3.269

5.  Biosafety evaluation of bacteriophages for treatment of diarrhea due to intestinal pathogen Escherichia coli 3-2 infection of chickens.

Authors:  Hao Li; Man-Li Ma; Hui-Jun Xie; Jian Kong
Journal:  World J Microbiol Biotechnol       Date:  2011-05-15       Impact factor: 3.312

Review 6.  Bacteriophage biocontrol of foodborne pathogens.

Authors:  Mustafa Kazi; Uday S Annapure
Journal:  J Food Sci Technol       Date:  2015-10-26       Impact factor: 2.701

7.  Bacteriophage Therapy Testing Against Shigella flexneri in a Novel Human Intestinal Organoid-Derived Infection Model.

Authors:  Alejandro Llanos-Chea; Robert J Citorik; Kourtney P Nickerson; Laura Ingano; Gloria Serena; Stefania Senger; Timothy K Lu; Alessio Fasano; Christina S Faherty
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-04       Impact factor: 2.839

Review 8.  Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.

Authors:  Krystyna Dąbrowska; Stephen T Abedon
Journal:  Microbiol Mol Biol Rev       Date:  2019-10-30       Impact factor: 11.056

9.  Novel virulent and broad-host-range Erwinia amylovora bacteriophages reveal a high degree of mosaicism and a relationship to Enterobacteriaceae phages.

Authors:  Yannick Born; Lars Fieseler; Janine Marazzi; Rudi Lurz; Brion Duffy; Martin J Loessner
Journal:  Appl Environ Microbiol       Date:  2011-07-15       Impact factor: 4.792

10.  Isolation and Comparative Genomic Analysis of T1-Like Shigella Bacteriophage pSf-2.

Authors:  Jin Woo Jun; Hyoun Joong Kim; Sae Kil Yun; Ji Young Chai; Byeong Chun Lee; Se Chang Park
Journal:  Curr Microbiol       Date:  2015-11-26       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.